Clinical trial
Ipratropium Bromide Spray as Treatment for Sialorrhea in Children: a Randomized, Double-blind, Placebo-controlled Crossover Study
NCT03747536 is registered in ClinicalTrials.gov with London Health Sciences Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ipratropium Bromide Spray as Treatment for Sialorrhea in Children: a Randomized, Double-blind, Placebo-controlled Crossover Study
- Lead sponsor
- London Health Sciences Centre
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 1, 2019
- Completion date
- January 1, 2021
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.